Prescription drug · BLA
Zevalin (Ibritumomab tiuxetan) NDC 72893-007
Kit · Acrotech Biopharma Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72893-007-04 | 7289300070472893000704 | 1 KIT in 1 CARTON (72893-007-04) * 10 mL in 1 VIAL * 2 mL in 1 VIAL * 2 mL in 1 VIALMarketed from Feb 19, 2002 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zevalin
- Generic name (nonproprietary)
- ibritumomab tiuxetan
- Dosage form
- Kit
- Labeler
- Acrotech Biopharma IncNDC labeler code 72893
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125019
- Marketing start
- Listing expires
- Identifiers
- Product ID 72893-007_c1ec6e37-45bb-4cda-a821-464552c48982SPL ID c1ec6e37-45bb-4cda-a821-464552c48982SPL set ID 25d367dc-da65-44c9-a844-1bf15339c285
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N472893000704followed by a unit qualifier and the quantityPackage 72893-0007-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Zevalin is a CD20-directed radiotherapeutic antibody administered as part of the Zevalin therapeutic regimen indicated for the treatment of adult patients with: relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL) ( 1.1 ). previously untreated follicular NHL who achieve a partial or complete response to first-line chemotherapy ( 1.2 ). 1.1 Relapsed or Refractory, Low-grade or Follicular NHL Zevalin is indicated for the treatment of adult patients with relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL). 1.2 Previously Untreated Follicular NHL Zevalin is indicated for the treatment of previously untreated follicular NHL in adult p…
Excerpt only. Read the full label for complete information.
About NDC 72893-007
- What is NDC 72893-007?
- 72893-007 is the product NDC for Zevalin (ibritumomab tiuxetan) kit, listed with the FDA by Acrotech Biopharma Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zevalin (Ibritumomab tiuxetan).
- Who is the labeler?
- Acrotech Biopharma Inc, NDC labeler code 72893. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zevalin?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.